# OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting

> **NCT04960722** · NA · COMPLETED · sponsor: **BioGend Therapeutics Co.Ltd** · enrollment: 35 (actual)

## Conditions studied

- Tibia Fracture

## Interventions

- **DEVICE:** OIF/β-TCP

## Key facts

- **NCT ID:** NCT04960722
- **Lead sponsor:** BioGend Therapeutics Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-11
- **Primary completion:** 2024-09-24
- **Final completion:** 2025-02-25
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04960722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04960722, "OIF/β-TCP in Patients With Open Tibial Fractures in Need of Bone Grafting". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04960722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*